The Uromigos

401 Episodes

1. Episode 383: A Neoantigen Vaccine Generates Anti-tumor Immunity in RCC

   Published: 2/5/2025
2. Episode 382: Uromigos Japan - TROPICs-04の考察

   Published: 2/5/2025
3. Episode 381: Molecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockade

   Published: 1/27/2025
4. Episode 380: The Role of SBRT in RCC

   Published: 1/13/2025
5. Episode 379: Uromigos Japan: 2024年のGU Oncologyを振り返る

   Published: 1/10/2025
6. Episode 378: 2025 Preview of Important GU Data

   Published: 1/6/2025
7. Episode 377: Prostate Cancer 2024 Highlights

   Published: 12/23/2024
8. Episode 376: Bladder Cancer 2024 Highlights

   Published: 12/23/2024
9. Episode 375: Renal Cancer 2024 Highlights

   Published: 12/23/2024
10. Episode 374: Mechanisms of HIF Resistance

    Published: 12/18/2024
11. Episode 373: KEYNOTE-564 Asian OSとANNARの解説

    Published: 12/11/2024
12. Episode 372: FDA Accelerated Approval Process

    Published: 12/9/2024
13. Episode 371: TROPICS-04 Results from ESMO Asia

    Published: 12/7/2024
14. Episode 370: Artificial Intelligence in Medical Oncology

    Published: 12/2/2024
15. Episode 369: Paper of the Month with Bishoy Faltas

    Published: 11/25/2024
16. Episode 368: Radiomics in RCC: Live from IKCS

    Published: 11/19/2024
17. Episode 367: Abiraterone vs AR inhibitors (Fanta vs Coke) in Prostate Cancer

    Published: 11/11/2024
18. Episode 366: ARPIs in Prostate Cancer - Are They Different?

    Published: 11/4/2024
19. Episode 365: A Review of the Advanced Prostate Cancer Consensus Conference (APCCC)

    Published: 10/28/2024
20. Episode 364: 腎がんの最新の話題〜IO rechallengeと乳頭型腎がんの治療戦略〜

    Published: 10/24/2024